Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:4-[1-(cyclopropylmethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyrimidin-2-amine
go back to main search page
Accession:CHEBI:45452 term browser browse the term
Definition:An aminopyrimidine that has formula C17H16FN5.


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 23757
    chemical entity 23720
      atom 23706
        nonmetal atom 23356
          halogen 19114
            fluorine atom 12066
              fluorine molecular entity 12066
                organofluorine compound 11386
                  4-[1-(cyclopropylmethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyrimidin-2-amine 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 23757
    subatomic particle 23706
      composite particle 23706
        hadron 23706
          baryon 23706
            nucleon 23706
              atomic nucleus 23706
                atom 23706
                  main group element atom 23525
                    p-block element atom 23525
                      carbon group element atom 23236
                        carbon atom 23213
                          organic molecular entity 23213
                            organic molecule 23075
                              organic cyclic compound 22093
                                organic heterocyclic compound 20730
                                  heteroarene 17129
                                    monocyclic heteroarene 14197
                                      azole 13436
                                        diazole 8869
                                          imidazoles 8180
                                            4-[1-(cyclopropylmethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyrimidin-2-amine 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.